CARMIEL, Israel--(BUSINESS WIRE)--Protalix BioTherapeutics, Inc. (Amex: PLX), today announced that Dr. David Aviezer, the Company’s President and Chief Executive Officer, will be presenting at the 7th National Life Science Week, Biomed Conference and at the 2008 Bio International Convention. Additionally, the Company will be giving a presentation on its ongoing clinical development program for the treatment of Gaucher Disease at the 8th European Working Group on Gaucher Disease Meeting.
